ISRG Reports Strong Q3 2025 Profit and Revenue Growth

Intuitive (ISRG.US) announced strong financial results for the third quarter of 2025, with non-GAAP net income attributable to Intuitive reaching $867 million, or $2.40 per diluted share. This represents a substantial increase of 29.6% compared to $669 million, or $1.84 per diluted share, in the third quarter of 2024. Total revenue for the quarter was $2.51 billion, up 23% from $2.04 billion in the prior year quarter, and exceeding the analyst estimate of $2.41 billion.

Procedure and System Growth Drive Performance

The company's robust financial performance was largely driven by significant growth in procedure volumes and da Vinci system placements. Worldwide procedures (da Vinci and Ion combined) increased by approximately 20% year-over-year, with da Vinci procedures growing 19% and Ion procedures surging by approximately 52%. This strong procedural growth directly contributed to the 20% increase in instruments and accessories revenue, which reached $1.52 billion.

Intuitive placed 427 da Vinci surgical systems during the quarter, a notable increase from 379 systems in the third quarter of 2024. A key highlight was the placement of 240 da Vinci 5 systems, significantly up from 110 in the same period last year, indicating strong adoption of the latest technology. The installed base for da Vinci systems expanded by 13% to 10,763 systems, while the Ion endoluminal system installed base grew by 30% to 954 systems.

Management's Strategic Focus and Outlook

Intuitive's CEO, Dave Rosa, expressed satisfaction with the quarter's results, emphasizing the continued growth in customer adoption of both the Ion and da Vinci platforms, including the da Vinci 5. Management reiterated its focus on the Quintuple Aim: enhancing patient care, improving patient and care team experiences, expanding access to high-quality care, and reducing overall care costs.

For the full year 2025, the company expects worldwide da Vinci procedure growth to be approximately 17% to 17.5%. Non-GAAP gross profit margin is projected to be between 67% and 67.5% of revenue, which includes an estimated impact from tariffs. Non-GAAP operating expense growth is anticipated to be between 11% and 13% for the full year.